Obesity is a chronic inflammatory state and adipose tissue serves as a source of inflammatory mediators. This study compared plasma levels of the proinflammatory cytokines interleukin-6 (IL-6) and tumour necrosis factor-a (TNFa) in 20 morbidly obese patients (group O) undergoing laparoscopic Roux-en-Y gastric bypass surgery and in 20 non-obese control patients (group C) undergoing laparascopic gastrectomy. Blood was sampled preoperatively and at 3 and 24 h postoperatively. Postoperative IL-6 levels increased significantly in both groups, but were significantly lower in group O than in group C. Age-and anaesthetic timeadjusted IL-6 levels showed a significant increase at 24 h postoperatively compared with preoperative values in both groups; changes were significantly greater in group C. TNF-a levels did not change significantly over time, but were significantly lower in group O at 3 h postoperatively compared with group C. In conclusion, postoperative changes in IL-6 and TNF-a levels in morbidly obese patients were lower than in non-obese patients. Adipose tissue appears not to contribute to the acute postoperative inflammatory response.
Introduction
Obesity is associated with chronic low-grade inflammation and adipose tissue is a major source of inflammatory mediators. 1 -3 Adipocytes and macrophages in adipose tissue produce many inflammatory mediators including leptin, adiponectin, interleukin(IL)-6, tumour necrosis factor-α (TNF-α) and C-reactive protein. 4 Increased levels of IL-6 have been reported in obese patients 5 and show a strong correlation with adipose tissue, body mass index (BMI) and waist circumference. 6 Increased levels of TNFα mRNA in the adipose tissue of obese patients has also been reported, 7 although factors other than BMI (such as obstructive sleep apnoea) were thought to be the cause. 8 Levels of these cytokines decreased after weight loss. 9 -12 Chronic inflammation in obesity was reported to be an important link between cardiovascular disease and obesity, 4 and between metabolic syndrome and obesity. 13, 14 Recruitment of immune cells in the adipose tissue causes inflammation that contributes to insulin resistance and dyslipidaemia. 14 As obese patients have a rich supply of adipose tissue that produces inflammatory Adipose tissue and postoperative inflammatory cytokine response cytokines 1 -6 and, therefore, have elevated levels of such cytokines, for the present study it was hypothesized that the postoperative inflammatory response would be exaggerated in these patients. Consequently, plasma levels of IL-6 and TNF-α were measured in morbidly obese patients undergoing bariatric surgery; these levels were then compared with levels in non-obese patients undergoing laparoscopic gastrectomy for early gastric cancer or benign gastric tumours. Patients with infectious or inflammatory diseases, patients taking antiinflammatory drugs, and patients with serious postoperative surgical complications were excluded from the study because these conditions could influence the cytokine level. In group O, only patients with BMI ≥ 35 kg/m 2 were enrolled and, in group C, only patients with BMI ≤ 25 kg/m 2 were enrolled.
Patients and methods

STUDY POPULATION
The study protocol was approved by the Institutional Research Board of Yeouido St Mary's Hospital. Each patient provided written informed consent after receiving an explanation of the aims and methods of the study.
SURGICAL PROCEDURES
Patients entered the operating room without any premedication and were monitored with a non-invasive blood pressure monitor, electrocardiography and pulse oximetry. Induction of anaesthesia was achieved by intravenous (i.v.) injection of sodium pentothal 4 -5 mg/kg and succinylcholine 1 mg/kg. Following tracheal intubation, administration of desflurane 6%-nitrous oxide 2 l/min and oxygen 2 l/min commenced and was maintained throughout the surgical procedure. Vecuronium bromide was used for neuromuscular blockade, initially at a dose of 0.05 mg/kg i.v., with an additional 0.02 mg/kg administered i.v. as needed. In each patient in group O, laparoscopic Roux-en-Y gastric bypass was performed. In each patient in group C, laparoscopic subtotal gastrectomy and Billroth II anastomosis was performed. After surgery, patients recovered from anaesthesia and were extubated.
BLOOD SAMPLING AND CYTOKINE ANALYSIS
Venous blood (3 ml) was sampled from each patient from forearm veins immediately prior to skin incision (preoperatively), and 3 and 24 h after the end of the operation (postoperatively) into bottles containing 5.4 mg of dried dipotassium ethylenediaminetetra-acetic acid. Blood samples were centrifuged at 1700 g for 10 min and the plasma was separated. Plasma samples were stored at -80°C. IL-6 was analysed using a human IL-6 Quantikine ® Colorimetric Sandwich enzyme-linked immunosorbent assay (ELISA) kit and TNF-α was analysed using a human TNF-α Quantikine ® Colorimetric Sandwich ELISA kit (R&D Systems, Minneapolis, MN, USA) according to the manufacturer's instructions. The minimum detectable level was < 0.70 pg/ml for IL-6 and the detectable range was 0.5 -5.5 pg/ml for TNF-α. Adipose tissue and postoperative inflammatory cytokine response
STATISTICAL ANALYSES
The sample-size calculation was based on the difference in the log e (IL-6) change being ≥ 1.7 (5.47 pg/ml on the original scale) at 24 h postoperatively between the two groups. Power analysis suggested that a sample size of 17 patients in each group should be adequate to detect a difference between the two groups, with a two-sided significance level of α = 0.05 and a power of 0.9. A dropout rate of 10% was assumed and the sample size was, therefore, increased to 20 patients per group.
For statistical analysis, the two-sample t-test and the χ 2 -test were performed for comparison of baseline characteristics between the two groups. Between-group differences in IL-6 and TNF-α levels, and changes over time in each group, were analysed by the Wilcoxon signedrank test and the Friedman test. Log e scales of IL-6 after adjusting for age and anaesthetic time between the two groups were compared by repeated-measures analysis of covariance. Statistical analyses were performed using the SPSS ® software package, version 14.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . A value of P < 0.05 was considered to be statistically significant.
Results
A total of 20 morbidly obese patients scheduled for laparoscopic bariatric surgery (group O) and 20 non-obese patients (controls) scheduled for laparoscopic gastrectomy (group C) were enrolled in the study. Baseline demographic and clinical data for each group are shown in Table 1 . As a result of the selection criteria for this study, there were significant between-group differences in age, weight, height and BMI (P ≤ 0.015 for all comparisons).
Preoperative plasma IL-6 levels were not significantly different between the two groups ( Table 2) . At 3 h and 24 h postoperatively, the plasma IL-6 levels in group O were significantly lower than in group C (P = 0.0021 and 0.0004, respectively). Both groups showed a significant increase in plasma IL-6 levels at 3 h and 24 h postoperatively compared with preoperative levels (P < 0.0001 for both comparisons).
Preoperative plasma TNF-α levels were not significantly different between the two groups (Table 3) . At 3 h postoperatively, the plasma TNF-α level in group O was significantly lower than that in group C (P = NS, not statistically significant (P ≥ 0.05). Adipose tissue and postoperative inflammatory cytokine response 0.0094). There were no significant withingroup changes in TNF-α levels at 3 h and 24 h postoperatively. Age-and anaesthetic time-adjusted changes in IL-6 levels are given in Table 4 . Adjusted IL-6 levels were not different between the two groups at each time point. Both groups showed a significant increase in IL-6 levels at 3 h and 24 h postoperatively compared with preoperative levels (P < 0.0001 for both comparisons). The change in group C at 24 h postoperatively was significantly greater than that in group O (P = 0.0146).
Discussion
The present study was conducted to establish the role of adipose tissue in the inflammatory response during the postoperative period. Beyond the chronic inflammatory state associated with morbid obesity, we thought that adipose tissue would have a significant role in postoperative inflammation, due to the rich supply of such tissue acting as a source of inflammatory mediators. 1 -6 To our knowledge, postoperative inflammatory responses in morbidly obese patients have not yet been reported in the literature.
In patients with surgical injuries, cytokines are released from diverse cell types at the site of injury and from immune cells, systemically. 15, 16 Intraoperative or early postoperative production of M-Y Chung, S-J Hong, J-Y Lee Adipose tissue and postoperative inflammatory cytokine response proinflammatory cytokines is initiated by macrophages and monocytes at the initial site of injury, as part of an acute-phase response. 17 Even though initiation of the acute-phase response begins at the initial site of injury, cytokines also originate from systemic immune cells including macrophages and monocytes. 15 Among the proinflammatory cytokines, TNF-α and IL-1β exert crucial roles during an acute-phase response. 17 Unlike sepsis, multiple trauma or blood loss, elective major surgery has not been shown to induce major changes in systemic TNF-α and IL-1β levels during the postoperative period. 18 This may be because these cytokines exert their physiological activity close to the site of release, or because the peak levels were missed during the analyses: both cytokines have short half-lives (up to 20 min). 18 TNF-α and IL-1β stimulate the production and release of other cytokines, including IL-6, which has a marked peak level at 4 -48 h after surgery. 19 The current study, therefore, measured postoperative changes in TNF-α and IL-6 levels.
Levels of IL-6 increase with adiposity, and approximately 30% of total circulating IL-6 originates from adipose tissue in healthy patients. 20 In addition, weight loss after surgery in obese patients is associated with a reduction in inflammatory cytokine concentrations. 10,12 Moderate weight loss does not, however, ameliorate the inflammatory state. 21 Busetto et al. 22 reported acutely increased levels of Creactive protein and IL-6 after ultrasoundassisted megalipoplasty, which then returned to baseline levels. Unlike reports that have focused on the longitudinal changes in inflammatory cytokines in obese patients, the aim of the present study was to compare postoperative cytokine changes in morbidly obese and non-obese patients.
No significant differences in preoperative IL-6 and TNF-α levels were observed between the two groups in the present study. In contrast, others have reported that levels of inflammatory molecules were highly correlated with adiposity or obesity-related problems. 5,7,23 Preoperative IL-6 and TNF-α levels in morbidly obese patients in the present study were not significantly different from those of the non-obese (control) patients. It is possible that this unexpected result was due to patient factors. For example, bariatric surgery is not as popular in the Republic of Korea as it is in Western countries and most of the morbidly obese 
TABLE 4: Comparison of pre-and postoperative age-and anaesthetic time-adjusted interleukin-6 (IL-6) levels in morbidly obese patients scheduled for laparoscopic Roux-en-Y gastric bypass surgery (group O) and non-obese control patients scheduled for laparoscopic gastrectomy (group C) Adipose tissue and postoperative inflammatory cytokine response
patients in this study were younger than comparative patients elsewhere: 24 the mean age was only 28 years in the present study. Consequently, these younger morbidly obese patients were less likely to have cardiovascular morbidity compared with older morbidly obese patients. Obesity affects endothelial cell function 25 and is a risk factor for cardiovascular disease, atherosclerosis and diabetes; indeed, inflammation acts as a major driver in the pathogenesis of these conditions. 4 The possible relatively lower incidence and shorter duration of cardiovascular and metabolic disease in the morbidly obese patients in the present study (because they were relatively young) might have resulted in lower inflammatory cytokine levels than those reported in other studies involving obese patients. 5,7,10,12, 20, 23 In addition, because of its surgical similarity with the Roux-en-Y gastric bypass that was performed in the morbidly obese patients, the non-obese control group in the present study included those undergoing laparoscopic gastrectomy for benign tumours or early gastric cancer. Patients with gastric cancer have been reported to have elevated levels of IL-6, however, 26 and gastric cancer might have contributed to the increased IL-6 levels observed in the control group, reported here. The specific patient characteristics of the morbidly obese and non-obese groups appear to have resulted in there being no significant between-group differences in preoperative IL-6 and TNF-α levels.
Contrary to the current hypothesis, in the present trial, postoperative IL-6 levels were significantly lower in the morbidly obese patients than in the non-obese controls at both 3 h and 24 h postoperatively, and postoperative TNF-α levels were also significantly lower in the morbidly obese group than in the controls at 3 h postoperatively. IL-6 is produced by adipocytes and macrophages in adipose tissue, and levels appear to be correlated with the extent of obesity. 27, 28 Fain 29 concluded that IL-6 and TNF-α were released mainly by the non-fat cells of human adipose tissue. The non-fat cells responsible for the release of inflammatory mediators are macrophages recruited in the adipose tissue; endothelial cells, fibroblasts and other mononuclear cells are less established as candidates. 29 Between-group differences in postoperative IL-6 and TNF-α levels might be caused by the activation of inflammatory cells by different stimuli. The degree of tissue trauma caused by the surgical procedures might have varied between the two groups. Even though patients undergoing laparoscopic gastrectomy were chosen as the non-obese control group, the two surgical procedures are not exactly the same and might have induced a different level of tissue trauma resulting in between-group variations in the inflammatory response.
Age is known to influence cytokine levels. 30 An age-and anaesthetic timeadjusted comparison of the log scale of IL-6 revealed significant changes from the baseline values in both groups reported here, with the amount of change being greatest in the non-obese control group. The plasma IL-6 level was significantly lower in the morbidly obese group than in the non-obese control group at 24 h postoperatively. It can be concluded, therefore, that the postoperative inflammatory change in plasma IL-6 level was greater in the nonobese control group.
Adipose tissue is one of the most poorly perfused tissue groups. Blood flow in adipose tissue after an overnight fast is typically around 3 ml blood/100 g tissue per min, compared with 1.5 ml blood/100 g tissue per min in skeletal muscle. 31 The maximum flow • Received for publication 26 June 2011 • Accepted subject to revision 26 July 2011
• Revised accepted 5 November 2011 Copyright © 2011 Field House Publishing LLP increase in skeletal muscle is up to 20-fold, but only up to four-fold in adipose tissue. 32 As adipose tissue expands in obesity, adipocytes become more distant from the vasculature. 33 Increased adipose tissue mass without adequate vascular support might lead to hypoxia, macrophage infiltration and inflammation. 34 It is possible that proinflammatory mediators stimulating inflammatory cells in adipose tissue could arrive very late (or in reduced amounts) in obese patients compared with normoweight patients, because poor perfusion and low blood flow induce a delayed inflammatory response. Compared with non-obese patients, plasma sampling should be continued for a longer postoperative period in patients who are obese, to explore the possibility of a time delay in the postoperative inflammatory response between the two groups.
A study by Montalbán et al. 35 reported that TNF-α levels were decreased after vertical gastroplasty with etomidate and thiopental anaesthesia, although a significant difference was only demonstrated in the etomidate group. Gastric surgery in obese patients may induce inhibition of TNFα secretion from adipose tissue. 35 The present study induced anaesthesia with sodium thiopental, and postoperative TNF-α levels did not change.
The present study had several limitations. First, IL-6 and TNF-α do not represent all aspects of the acute inflammatory response. In obese patients, activation of the innate immune system is measured by circulating concentrations of myeloperoxidase and calprotectin. 36 Thus, elevation of these two markers in obese individuals represents continuous activation of the innate immune system, especially neutrophil activation, resulting in chronic inflammation. Myeloperoxidase and calprotectin were not measured in the present study. It is, therefore, not possible to determine whether these two factors contributed to acute postoperative inflammation. Secondly, the surgical procedures were not the same for the two groups. The Roux-en-Y gastric bypass procedure was used for making the gastric pouch and antegastric Roux limb anastomosis, and side-to-side jejunojejunostomy; laparoscopic gastrectomy was undertaken as a consecutive subtotal gastrectomy and Billroth II anastomosis in the control group. 37 In light of the results from the present study, it is possible that these two surgical procedures might induce different inflammatory responses. Thirdly, C-reactive protein levels were not assessed. They have been shown to be changed in bariatric surgery and appeared to be a more sensitive and specific marker of inflammation than IL-6 or TNF-α. 38, 39 There has been increasing concern about whether the role of IL-6 is beneficial or destructive. 40 Thus, it is not possible to conclude that the lower level of IL-6 reported here in morbidly obese surgical patients was a positive phenomenon. Postoperative changes in cytokine levels, especially IL-6, were lower in the morbidly obese surgical patients than in the non-obese surgical patients. Adipose tissue, which induces chronic inflammation in obesity appears, therefore, not to contribute to the acute postoperative inflammatory response.
